Aging Female Population and Rising Awareness Propel the Global Cervical Cancer Screening Market

One of the most widespread cancer diseases in Women globally is Cervical Cancer. Global Cervical Cancer Screening Market is forecast to be US$ 7 Billion by 2020.

Roswell, Georgia, August 8, 2017 /India PRwire/ -- Download full Report: http://www.renub.com/aging-female-population-and-rising-awareness-propel-the-global-cervical-cancer-screening-market-40-nd.php

One of the most widespread cancer diseases in Women globally is Cervical Cancer. Cervical cancer is a disease with the long hidden era, early on recognition and care of precancerous lesions were extremely effective in women who often take screening tests. Mostly in many incidences, the disease is recognized as Human Papilloma Virus (HPV) infection. But in many developed nations, the death rate because of cervical cancer screening has fallen down. Global Cervical Cancer Screening Market is forecast to be US$ 7 Billion by 2020.

How Cervical Cancer Occurs & their Symptoms

In cervical cancer malignant tumor is in the lower most part of the uterus (womb). Symptoms consist of bleeding in between periods and after sexual intercourse. Pain may also occur in lower back pain or lower abdominal and foul smelling white discharge. There are many cases when there are no symptoms found.

The Cervical cancer can be prevented by HPV vaccine as well as PAP smear screening. Surgery, Chemotherapy and Radiation are the treatment for cervical cancer. Ages and their occurrence can be distinguished in following manners.

Ages Occurrences
0 to2 Never
3 to 5 Never
6 to 13 Never
14 to 18 Very Rare
19 to 40 Rare
41 to 60 Rare
60+

The Cervical cancer test includes Human Papilloma Virus (HPV) vaccine and PAP smear screening. Surgery, Chemotherapy and Radiation are the treatment for cervical cancer. Human Papilloma Virus (HPV) test occurs when the symptoms of HPV mainly causes infection in mouth, hand, genitals and fingers. Globally focus on HPV testing because of the rising awareness about and the link between HPV and Cervical cancer. PAP smear screening, been widely used as primary screening test for cervical cancer treatments. Changing the center on HPV testing as the primary screening test because of lower test sensitivity, higher negative results etc.

Cervical Cancer Test Market & Market Share: Overview

In Cervical cancer market 50 percent of the market share is jointly captured by the United States and Japan. In market research report, published by Renub Research found that Japan market will decline in future. The United Kingdom and France lead the cervical cancer market in Europe. Nations like India, China and Indonesia captures most of the cervical cancer test population.

Challenges in Cervical Cancer Globally

Globally challenges of cervical cancer are the scarcity of gynecologists and pathologists, lack of awareness of diseases, lack of government facilities and policies in low income nations.

The Report Studies the Global Cervical Cancer Screening Market on the basis of:
Countries

1. United Kingdom
2. France
3. Germany
4. Italy
5. Spain
6. Sweden
7. Switzerland
8. Norway
9. Netherlands
10. United States
11. Canada
12. Japan
13. Korea
14. Singapore
15. Malaysia
16. Australia
17. India
18. China
19. Thailand
20. Indonesia

Cervical Cancer Test Market

- Pap Smear Test Market & Forecast
- HPV DNA Test Market & Forecast
- VIA Test Market & Forecast

Web: www.renub.com

Notes to Editor

Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets.

Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.


Renub Research recent press release(s)


Pediatric Proton Therapy Market is expected to cross US$ 700 Million

By the year 2021, Pediatric Proton Therapy Market is expected to cross US$ 700 Million. Even if treating cancer with a low risk of side effects is the main concern for every patient, it's especially important when treating cancer in children.